3M (NYSE: MMM | MMM Price Prediction) reports Q1 2026 earnings on April 21 before the market opens. After losing its Dividend King status in 2024 and navigating a volatile start to 2026, this print is a real test of whether the transformation is durable.
Momentum Interrupted, Then Rebuilt
3M had been one of the market’s better recovery stories heading into this year. Shares gained 17.55% over the past 12 months, comfortably outpacing the broader market. But 2026 opened with turbulence. The stock is down 5.54% year-to-date after a sharp February pullback, though it has since recovered ground and trades near $156.
The Q4 2025 report set a solid foundation. Adjusted EPS came in at $1.83, beating the $1.79 estimate by 2.23%. Revenue of $6.13 billion beat estimates by 12.67% and grew 2.05% year-over-year. Adjusted operating margin expanded 140 basis points to 21.1%. The GAAP picture was messier, with $185 million in PFAS litigation charges and $235 million in PFAS product exit charges weighing on reported results. Critically, 3M completed its exit from manufactured PFAS products by year-end 2025, a meaningful overhang that is now behind them. CEO William Brown sounded confident heading into 2026: “Our accelerated pace of innovation and commercial execution positions us to outperform the macro environment again in 2026.”
Consensus Estimates
| Metric | Q1 2025 Actual | Q1 2026 Estimate | FY2025 Actual | FY2026 Guidance Midpoint |
|---|---|---|---|---|
| Adjusted EPS | $1.88 | ~$2.08 | $8.06 | $8.60 |
| Revenue | $5.954B | ~$6.10B | $24.948B | ~4% growth guided |
Tariffs, Margins, and the Innovation Bet
The biggest variable heading into this print is tariff exposure. In Q1 2025, management flagged a $0.20 to $0.40 per share sensitivity from tariffs. That risk is live again in Q1 2026, and the trade environment has intensified since then. Management built a $0.20 EPS carryover impact into 2026 guidance, mostly weighted to the first half. Whether that estimate holds or gets revised upward will be a key signal from management.
Margins are the other key story. The 3M eXcellence operating model has delivered consistent expansion across every quarter of 2025, from 23.5% in Q1 to 24.7% in Q3. Q4 dipped to 21.1% due to litigation charges, but the underlying operational discipline looks intact. Full-year 2026 guidance calls for 70 to 80 basis points of adjusted operating margin expansion. The key question is whether Q1 stays on that trajectory or whether tariff and currency headwinds squeeze the line.
On the innovation front, 3M launched 284 new products in 2025, up 68% versus 2024, and is targeting 350 launches in 2026. Sales from products introduced in the last five years were up 23% for the full year. That pipeline is increasingly the engine of organic outperformance, and management expects innovation to account for roughly half of the $300 million of outperformance versus macro in 2026.
Segment-level, Safety and Industrial is the one to watch. It delivered 6.0% organic growth in Q4 and has been the company’s most consistent performer. Transportation and Electronics has been soft, and Consumer remains a drag, though management guided for Consumer to return to growth in 2026. China, which grew mid-single digits in 2025, is a wildcard given the current trade environment. Any commentary on China and EMEA trends will shape how investors read the geographic picture.
Credibility Is the Real Deliverable
3M has beaten EPS estimates in all eight consecutive quarters through 2024 and 2025. But the stock’s reaction to beats has been uneven, including a 6.96% drop on Q4 earnings day despite the beat. Investors need confidence that 2026 guidance holds in a more uncertain macro environment, that PFAS is truly in the rearview, and that the transformation is compounding. A beat alone is unlikely to move sentiment. If Brown reaffirms the path to a 25% operating margin by 2027, sentiment could shift quickly.